Developer docs
API playgroundTry for free, no card

Search company profiles

InflamaCORE

Full company profile

uuid0034fbb

Namestring
InflamaCORE
Legal namestring
InflamaCORE, LLC
Websiteurl
inflamacore.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

InflamaCORE, LLC is a privately held company headquartered in Miami, Florida, that states a focus on diagnosing and treating inflammatory diseases. The entity operates as a single-member-style LLC with no disclosed parent, subsidiary, or institutional investor relationships, and is led by Chief Executive Officer Stephen C. Glover. The company's public footprint is limited to a basic GoDaddy-hosted website (inflamacore.com) and a single contact email (JDeRivero@inflamacore.com), with no product descriptions, pricing, customer segments, partnerships, or technology disclosures available in the input data.

The company was established in 2022 according to company history records and the website copyright notice, though firmographic data references 2009 — the 2022 date is treated as primary given direct corroboration from corporate records. No products, services, technology platforms, proprietary features, patents, certifications, or clinical pipeline are disclosed in the available source material, leaving the specific diagnostic or therapeutic offering undefined.

There is no disclosed revenue, funding history, headcount, pricing model, or go-to-market motion. The company has not announced institutional investment, M&A activity, partnerships, or product launches. Markets served are characterized as North America. Given the minimal disclosure, the company's current operational status appears to be early-stage or pre-commercial, with significant information gaps that limit financial and strategic assessment.

Short descriptiontext

InflamaCORE is a privately held Miami-based LLC that states a focus on diagnosing and treating inflammatory diseases. The company has minimal public disclosure, with no products, pricing, customers, or funding detailed in available data.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMiami, United States
HQ citystring
Miami
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
inflammatory disease diagnostics, inflammatory disease treatment, specialty healthcare services, clinical inflammation care, medical diagnostic services
Industry2 codes
PRIMARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHLAGANAH
Microbiome & Metagenomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
NAICS code2 codes
  • Medical and Diagnostic Laboratories6215
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Specialty Healthcare / Inflammatory Disease Diagnostics
Cost components3 values
Personnel, Operations, Technology or R&D
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

InflamaCORE is a specialty healthcare services company that focuses on diagnosing and treating inflammatory diseases. It operates as a private LLC providing clinical diagnostic and treatment services to patients suffering from inflammatory conditions, supported by an in-house technology capability referenced on its website.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Inflammatory Disease Diagnostic & Treatment Services
CategorySpecialty Healthcare Services
Description

Clinical diagnostic and treatment services for patients with inflammatory diseases, as described by the company's stated specialization. Specific service lines, modalities, and protocols are not disclosed in the available source material.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global laboratory services group with clinical diagnostics capabilities including inflammation and autoimmune testing panels. Comparable as a multi-region diagnostics provider overlapping with InflamaCORE's inflammatory-disease testing and treatment-monitoring potential.

2Singulex
TypeEmerging player
Description

Developer of ultra-sensitive single-molecule immunoassay technology for inflammatory biomarker detection (e.g., IL-6, TNF-alpha). Comparable as a technology-focused inflammation biomarker company with partial overlap in measuring low-abundance inflammatory analytes.

TypeBroad incumbent
Description

Global biopharma leader in immunology and inflammation therapeutics (Humira, Rinvoq, Skyrizi). Comparable on the therapeutic side of InflamaCORE's stated mission; a major incumbent any inflammation-treating venture must compete against or partner with.

TypeBroad incumbent
Description

Major biopharma with significant inflammation and immunology franchises (e.g., Cibinqo, Xeljanz, etrasimod). Comparable as a large, well-capitalized therapeutic competitor in the inflammatory disease treatment market InflamaCORE is targeting.

5Crescendo Bioscience
TypeDirect peer
Description

Developed the Vectra DA test for rheumatoid arthritis disease activity, a blood-based multi-biomarker inflammation diagnostic. Directly comparable as a specialty inflammation diagnostics platform serving autoimmune patients and rheumatologists.

TypeDirect peer
Description

Specializes in diagnostic testing for inflammatory and autoimmune gastrointestinal diseases (e.g., IBD, Crohn's). Directly comparable to InflamaCORE's stated mission of diagnosing and treating inflammatory diseases, particularly in the gastroenterology-focused inflammation niche.

TypeBroad incumbent
Description

Diversified molecular diagnostics company with autoimmune and inflammation-relevant products (including acquired Crescendo Bioscience assets). Broader portfolio than InflamaCORE but overlapping in inflammation/autoimmune diagnostics and treatment-decision support.

TypeBroad incumbent
Description

Largest US clinical laboratory offering broad inflammation and autoimmune test panels (e.g., CRP, ANA, cytokine assays). Comparable as a diagnostic-services backbone in inflammatory disease testing, though far broader in scope than a specialized inflammation player.

TypeBroad incumbent
Description

Major clinical lab network with extensive autoimmune and inflammatory disease test menu. Comparable as a large-scale diagnostics provider overlapping with InflamaCORE's diagnostic ambitions, but operates across all major lab categories.

TypeEmerging player
Description

Provides multiplexed assays for cytokines, chemokines, and other inflammatory biomarkers used in research and clinical studies. Comparable on the inflammation biomarker measurement axis, though primarily research-use rather than clinical-diagnostic focused.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

InflamaCORE

Specialty Healthcare / Inflammatory Disease Diagnosticsinflamacore.com

InflamaCORE is a privately held Miami-based LLC that states a focus on diagnosing and treating inflammatory diseases. The company has minimal public disclosure, with no products, pricing, customers, or funding detailed in available data.

What InflamaCORE does

InflamaCORE, LLC is a privately held company headquartered in Miami, Florida, that states a focus on diagnosing and treating inflammatory diseases. The entity operates as a single-member-style LLC with no disclosed parent, subsidiary, or institutional investor relationships, and is led by Chief Executive Officer Stephen C. Glover. The company's public footprint is limited to a basic GoDaddy-hosted website (inflamacore.com) and a single contact email (JDeRivero@inflamacore.com), with no product descriptions, pricing, customer segments, partnerships, or technology disclosures available in the input data.

The company was established in 2022 according to company history records and the website copyright notice, though firmographic data references 2009 — the 2022 date is treated as primary given direct corroboration from corporate records. No products, services, technology platforms, proprietary features, patents, certifications, or clinical pipeline are disclosed in the available source material, leaving the specific diagnostic or therapeutic offering undefined.

There is no disclosed revenue, funding history, headcount, pricing model, or go-to-market motion. The company has not announced institutional investment, M&A activity, partnerships, or product launches. Markets served are characterized as North America. Given the minimal disclosure, the company's current operational status appears to be early-stage or pre-commercial, with significant information gaps that limit financial and strategic assessment.

InflamaCORE firmographics

Firmographics
Name
InflamaCORE
Legal name
InflamaCORE, LLC
Website
https://inflamacore.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
InflamaCORE is a privately held Miami-based LLC that states a focus on diagnosing and treating inflammatory diseases. The company has minimal public disclosure, with no products, pricing, customers, or funding detailed in available data.
Ownership category
akta.pro rank

InflamaCORE industry classification

Industry
Product category
Specialty Healthcare / Inflammatory Disease Diagnostics
NAICS
Medical and Diagnostic Laboratories (6215), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHLAGANAH
Microbiome & Metagenomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • Inflammatory disease diagnostics
  • Inflammatory disease treatment
  • Specialty healthcare services
  • Clinical inflammation care
  • Medical diagnostic services

Where InflamaCORE is headquartered

Location

Headquarters

HQ city
Miami
HQ country
United States
HQ region
North America

Offices1 record

Markets served

InflamaCORE business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D

InflamaCORE product offering

Product offering

Core offering

InflamaCORE is a specialty healthcare services company that focuses on diagnosing and treating inflammatory diseases. It operates as a private LLC providing clinical diagnostic and treatment services to patients suffering from inflammatory conditions, supported by an in-house technology capability referenced on its website.

Differentiator

Problem solved

Functional benefit

Products and services

  • Inflammatory Disease Diagnostic & Treatment Services Clinical diagnostic and treatment services for patients with inflammatory diseases, as described by the company's stated specialization. Specific service lines, modalities, and protocols are not disclosed in the available source material.

Companies that use InflamaCORE

Customer profile

Ideal customer profiles1 record

InflamaCORE technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

InflamaCORE partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights1 record

InflamaCORE competitors and assessment

Company assessment

Broad incumbents

  • Eurofins Scientific: Global laboratory services group with clinical diagnostics capabilities including inflammation and autoimmune testing panels. Comparable as a multi-region diagnostics provider overlapping with InflamaCORE's inflammatory-disease testing and treatment-monitoring potential.
  • AbbVie: Global biopharma leader in immunology and inflammation therapeutics (Humira, Rinvoq, Skyrizi). Comparable on the therapeutic side of InflamaCORE's stated mission; a major incumbent any inflammation-treating venture must compete against or partner with.
  • Pfizer: Major biopharma with significant inflammation and immunology franchises (e.g., Cibinqo, Xeljanz, etrasimod). Comparable as a large, well-capitalized therapeutic competitor in the inflammatory disease treatment market InflamaCORE is targeting.
  • Myriad Genetics: Diversified molecular diagnostics company with autoimmune and inflammation-relevant products (including acquired Crescendo Bioscience assets). Broader portfolio than InflamaCORE but overlapping in inflammation/autoimmune diagnostics and treatment-decision support.
  • Quest Diagnostics: Largest US clinical laboratory offering broad inflammation and autoimmune test panels (e.g., CRP, ANA, cytokine assays). Comparable as a diagnostic-services backbone in inflammatory disease testing, though far broader in scope than a specialized inflammation player.
  • Laboratory Corporation of America (Labcorp): Major clinical lab network with extensive autoimmune and inflammatory disease test menu. Comparable as a large-scale diagnostics provider overlapping with InflamaCORE's diagnostic ambitions, but operates across all major lab categories.

Emerging players

  • Singulex: Developer of ultra-sensitive single-molecule immunoassay technology for inflammatory biomarker detection (e.g., IL-6, TNF-alpha). Comparable as a technology-focused inflammation biomarker company with partial overlap in measuring low-abundance inflammatory analytes.
  • Meso Scale Diagnostics: Provides multiplexed assays for cytokines, chemokines, and other inflammatory biomarkers used in research and clinical studies. Comparable on the inflammation biomarker measurement axis, though primarily research-use rather than clinical-diagnostic focused.

Direct peers

  • Crescendo Bioscience: Developed the Vectra DA test for rheumatoid arthritis disease activity, a blood-based multi-biomarker inflammation diagnostic. Directly comparable as a specialty inflammation diagnostics platform serving autoimmune patients and rheumatologists.
  • Prometheus Laboratories: Specializes in diagnostic testing for inflammatory and autoimmune gastrointestinal diseases (e.g., IBD, Crohn's). Directly comparable to InflamaCORE's stated mission of diagnosing and treating inflammatory diseases, particularly in the gastroenterology-focused inflammation niche.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat1 record

Key risks6 records

Key highlights4 records

Customer concentration

InflamaCORE social profiles

Digital presence

InflamaCORE financial estimates

Financial estimate

Revenue estimate

Valuation estimate

InflamaCORE leadership team

Management profile

Number of profiles

Profiles1 record

InflamaCORE funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

InflamaCORE M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InflamaCORE

What does InflamaCORE do?

InflamaCORE is a specialty healthcare services company that focuses on diagnosing and treating inflammatory diseases. It operates as a private LLC providing clinical diagnostic and treatment services to patients suffering from inflammatory conditions, supported by an in-house technology capability referenced on its website.

Is InflamaCORE a public or private company?

InflamaCORE is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was InflamaCORE founded?

InflamaCORE was founded in 2022. It employs 1 to 10 people.

Where is InflamaCORE based?

InflamaCORE is headquartered in Miami, United States, in the North America region.

Who are InflamaCORE's main competitors?

Broad incumbents on record are Eurofins Scientific, AbbVie, Pfizer, Myriad Genetics, Quest Diagnostics and Laboratory Corporation of America (Labcorp). Emerging players are Singulex and Meso Scale Diagnostics. Direct peers are Crescendo Bioscience and Prometheus Laboratories.

Does InflamaCORE have an API?

No public API is recorded for InflamaCORE.

What industry is InflamaCORE in?

InflamaCORE's product category is Specialty Healthcare / Inflammatory Disease Diagnostics. Its primary akta.pro industry code is HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms, with a secondary code of HLAGANAH, Microbiome & Metagenomics Services. Its NAICS code is 6215 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales